2F5

Healthcare · EUR · F

2F5

Price

€0.421

+11.97%

Cap

€2.01M

Earnings

—

30d Trend

-9.3%

2F5

Loading chart data...

0 days · % change from startPowered by Brain47

BRAIN47 SIGNAL

WEAK

Risk Level85

Quality49

Momentum17

Technical38

Fundamentals50

Raw weighted: 31×Macro 0.99 (−1%)=31

RISK

85/100

90d Volatility

131.0%High

ATR %

15.6%High daily moves

Max Drawdown (1Y)

-86.2%Volatile

QUALITY

49/100

Piotroski F-Score

3/9Weak

Accruals

-19.6%Cash earnings

MOMENTUM

17/100

12-1M Momentum

-60.3%Strong downtrend

6-1M Momentum

-33.2%Negative

1M Return

-23.3%Sharp decline

Relative Strength

+1.2% vs sectorIn-line

TECHNICAL

38/100

RSI (14)

39.2Neutral

Price vs SMA200

-55.2%Bearish trend

MACD

-0.01Bearish momentum

Bollinger Band

17%Near lower band

SMA Cross

Golden CrossGolden Cross

Trend Quality (KER)

0.187Noisy/choppy

FUNDAMENTALS

50/100

Macro: neutral (×0.99) - Fear/Greed: 65 (Greed) - Data: 80%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months ★46

3-12 months22

1-5+ years38

Limited short-term thesis

BRAIN47'S ASSESSMENT

I rate 2F5 at 31/100 — a WEAK reading on the Brain47 Signal. The strongest factor is fundamentals at 50/100. I classify this as a speculative position with the strongest thesis on a short-term horizon.

DETAILED ANALYSIS

Limited short-term thesis. Fundamentals (50) and Quality (49) are the primary strengths. I note an elevated risk profile — this warrants closer monitoring. I classify this as a speculative position — elevated volatility at 131% and smaller market cap define the opportunity.

speculativeScore: 31/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.